a:5:{s:8:"template";s:5073:" {{ keyword }}
{{ text }}
";s:4:"text";s:6780:" Last week, Amgen said it’d cut 149 jobs in Massachusetts by the end of the year as it exits neuroscience R&D. 1 hospital in each state for 2020-21, 8 states reporting spikes in COVID-19 cases, deaths, 15 cities with the most new COVID-19 cases, deaths, 'Our backs are to the wall': Texas hospital to turn away COVID-19 patients with poor survival chances, Florida COVID-19 fatalities data included man who died in motorcycle accident, 10 physician specialties that generate the most revenue for hospitals, Former Tennessee hospital CEO says he was asked to resign after participating in surgery, Neck gaiters, bandanas more harmful than not wearing a mask, Duke study suggests, 10 cities most, least likely to bounce back from pandemic, per Moody’s Analytics, Trump signs executive orders on healthcare: 6 things to know, 10 best children's hospitals, ranked by US News, 25 hospitals getting biggest slice of $12B federal bailout fund, 8 drugs Trump has been given for his COVID-19 treatment, CDC adds 6 symptoms; young COVID-19 patients dying from strokes — 8 updates, Kaiser terminates employee that inappropriately accessed 2,756 patients' records over 8 years, Viewpoint: Hospital leadership is a bigger threat to nurses than COVID-19, How much federal COVID-19 aid are hospitals getting? But the sunny cartoon world wasn’t Novo’s original plan. To watch the virtual event held Sept. 17, click here. Pfizer, for instance, first announced its intention to halt neuroscience work in January 2018. View our policies by, Clinical Leadership & Infection Control E-Newsletter, Becker's Dental + DSO Review October Virtual Event, Becker's November CEO + CFO Virtual Event, Becker's Healthcare Post-Acute Virtual Forum, HC1 and Becker's Healthcare Precision Health Virtual Summit, Becker's Ambulatory Surgery Centers Podcast, Current Issue - Becker's Clinical Leadership & Infection Control, Past Issues - Becker's Clinical Leadership & Infection Control, 50 hospital and health system CNOs to know | 2020, Women hospital and health system CFOs to know, Missouri hospital CEO put on leave over personnel matter, 20 states record COVID-19 highs; Redfield warns of emerging threat — 4 updates, COVID-19 hospitalizations hit 6-week high; J&J pauses vaccine trial over 'unexplained illness' — 9 updates, Jefferson Health to cut 500 jobs, reduce executive pay, Missouri hospital worker allegedly sexually assaulted patient after snooping her medical records, Mayo Clinic to allow 1,500 employees to work from home long term, World sees 1M cases in 3 days; Trump no longer poses transmission risk, physician says — 4 COVID-19 updates, Intermountain Healthcare to cut 250 business positions, States ranked by COVID-19 test positivity rates: Oct. 14, 20 states where COVID-19 is spreading fastest, slowest: Oct. 14, COVID-19 patients may not recover sense of taste, smell after other symptoms end, States ranked by confirmed COVID-19 cases, COVID-19 hospitalizations by state: Oct. 14, 'I'm fighting a war against COVID-19 and a war against stupidity,' says CMO of Houston hospital, 5 health systems cutting physician salaries, COVID-19 does not easily spread via contaminated surfaces, CDC says, Updated COVID-19 peak dates, state by state, Tens of thousands of Americans apply for contact tracing jobs: 5 things to know, The No. We'll e-mail you a link to set a new password. Negative earnings could be a catalyst for layoffs so keep your ears open. Now we hear that Dewpoint has recruited Ameet Nathwani to the executive suite as the new CEO, who’s taking the helm from Polaris managing partner Amir Nashat, who brought the company into existence. The U.S. government will pay $31 million to Cytiva, formerly GE Life Sciences, to scale capacity for COVID-19 vaccine components across two states. Did Vaxart exaggerate Warp Speed role to enrich insiders. GlaxoSmithKline CEO Emma Walmsley is adding a royal title to her name. The stock is coming back down to earth and we all know what happens when Amgen stock starts having trouble.....layoffs!!!! But it had already cleared another randomized controlled trial and the agency determined the benefits at a time of growing drug resistance outweighed the risk. Like post, Posted 9 months ago When […], Medical Alley recently interviewed Borderless co-founder Andrew Kris to learn how the firm has been operating through the pandemic and its perspectives on life, business, and its lifesciences clients. If you can't find your hospital or surgery center, please let us know and we'll get a board created right away. The move to exit neuroscience R&D follows the decision by Amgen and its partner Novartis to stop pivotal tests of CNP520 in Alzheimer’s disease. Novo Seeds’ Jeroen Bakker thinks he’s found the next kinases.  medtechy, copyright 2020 Medtechy Inc. ⋅ Submit A Tip ⋅ Terms of Use ⋅ Privacy Policy ⋅ DMCA Policy ⋅ Removal Policy ⋅ [email protected], Laboratory/Diagnostic Sales General Discussion, Hospitals and Healthcare Facilities General Discussion, Politics of Healthcare General Discussion, Andreessen Horowitz Launches Third Bio Fund. Posted 12 months ago Neuroscience wasn’t the only unit that’s being hit by a reorganization underway at Amgen. Repurposing approved compounds for COVID-19 can expedite regulatory review, but changing formulation, dosing, and administration route may add risks. exclude terms. Amgen’s decision to exit neuroscience follows the shuttering of an Eli Lilly facility focused on the field and the spinning out of Pfizer’s pipeline to create Cerevel Therapeutics. The reason we ask for your email address is to ensure the reporting feature is not abused. Thermo Fisher Scientific will build a $130 million Singapore facility to house two new drug and vaccine filling lines that will go online in 2022. ENDPOINTS by John Carroll & team — all the news at 11:30a ET, EARLY EDITIONby Arsalan Arif — skimmable links and news at 7:15a ET, New Dewpoint Therapeutics CEO Ameet Nathwani (Sanofi), Emma Walmsley, GSK CEO (Mandel Ngan/AFP via Getty Images), L to R: Jeroen Bekaert, Ivan Dimov and Nate Fernhoff, Orca Bio (Orca), by Arsalan Arif — skimmable links and news at 7:15a ET, Am­gen chops 172 more staffers in R&D, op­er­a­tions and sales amid neu­ro­science ex­it, rev­enue down­turn. Novartis — then Sandoz — had purchased Weissman’s spinout SyStemix in the ’90s, then scrapped it due to practical challenges. A few weeks ago Kite and Allogene founder Arie Belldegrun jumped into the expanded syndicate for a Boston-based biotech called Dewpoint Therapeutics — a Polaris-birthed venture that’s styled itself as a drug development pioneer out to craft a major pipeline. ";s:7:"keyword";s:25:"amgen neuroscience layoff";s:5:"links";s:837:"Transgenic Technology In Animals, Diamonds Direct San Antonio, I4 Accident Deltona Today, Phoenix Concert Hall Capacity, Debary Tornado, Houses For Sale St Thomas, Johnny Williams Rugby Highlights, ";s:7:"expired";i:-1;}